Thomas Lengauer
Affiliations: | Saarland University, Saarbrücken, Saarland, Germany |
Google:
"Thomas Lengauer"Cross-listing: Computational Biology Tree
Parents
Sign in to add mentor| Robert Endre Tarjan | grad student | 1979 | Stanford | |
| (Upper and lower bounds on time-space tradeoffs in a pebble game) | ||||
Children
Sign in to add trainee| Niko Beerenwinkel | grad student | 2004 | Saarland University (Evolution Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Di Teodoro G, Pirkl M, Incardona F, et al. (2024) Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1. Bioinformatics (Oxford, England). 40 |
| Rossetti B, Incardona F, Di Teodoro G, et al. (2023) Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network). Tropical Medicine and Infectious Disease. 8 |
| Pirkl M, Büch J, Devaux C, et al. (2023) Analysis of mutational history of multidrug-resistant genotypes with a mutagenetic tree model. Journal of Medical Virology. 95: e28389 |
| Fröhlich H, Balling R, Beerenwinkel N, et al. (2018) From hype to reality: data science enabling personalized medicine. Bmc Medicine. 16: 150 |
| Döring M, Büch J, Friedrich G, et al. (2018) geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data. Nucleic Acids Research |
| Pironti A, Pfeifer N, Walter H, et al. (2017) Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool. Plos One. 12: e0174992 |
| Pironti A, Walter H, Pfeifer N, et al. (2016) Determination of Phenotypic Resistance Cutoffs from Routine Clinical Data. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Lengauer T, Pfeifer N, Kaiser R. (2015) Personalized HIV therapy to control drug resistance. Drug Discovery Today. Technologies. 11: 57-64 |
| Pironti A, Pfeifer N, Kaiser R, et al. (2014) Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences. Journal of the International Aids Society. 17: 19743 |
| Oette M, Reuter S, Kaiser R, et al. (2013) Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort. European Journal of Medical Research. 18: 48 |